
Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 2 chart positions in 2 markets.
By chart position
- 🇯🇵JP · Medicine#6710K to 30K
- 🇵🇪PE · Medicine#182500 to 3K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
5.3K to 17K🎙 Weekly cadence·118 episodes·Last published 6mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
11K to 33K🇯🇵91%🇵🇪9% - Active Followers
Loyal subscribers who consistently listen
3.1K to 9.9K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 10 epsHosts
Recent guests
Recent episodes
Mechanisms Underlying Alterations in Cardiac Conduction After Transcatheter Aortic Valve Replacement
Dec 10, 2025
18m 41s
From the JAMA Network: From ESC: Remote Monitoring for Atrial Fibrillation, Semaglutide and Tirzepatide in Patients With Heart Failure With Preserved Ejection Fraction, and more
Sep 16, 2025
38m 27s
Transthyretin Cardiac Amyloidosis in Older Black and Hispanic Individuals With Heart Failure
Sep 10, 2025
17m 34s
Clinical Outcomes With Personalized Accelerated Physiologic Pacing in HFpEF
Aug 27, 2025
20m 52s
Preserving and Promoting Clinical Trial Representativeness
Jul 30, 2025
16m 03s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 12/10/25 | Mechanisms Underlying Alterations in Cardiac Conduction After Transcatheter Aortic Valve Replacement✨ | cardiac conductiontranscatheter aortic valve replacement+3 | Alfred E. Buxton, MDMarie-France Poulin, MD | Mechanisms Underlying Alterations in Cardiac Conduction After Transcatheter Aortic Valve Replacement | — | cardiac conductiontranscatheter aortic valve replacement+3 | — | 18m 41s | |
| 9/16/25 | From the JAMA Network: From ESC: Remote Monitoring for Atrial Fibrillation, Semaglutide and Tirzepatide in Patients With Heart Failure With Preserved Ejection Fraction, and more✨ | remote monitoringatrial fibrillation+4 | Gregory CurfmanPhilip Greenland+1 | JAMA Network | — | remote monitoringatrial fibrillation+6 | — | 38m 27s | |
| 9/10/25 | Transthyretin Cardiac Amyloidosis in Older Black and Hispanic Individuals With Heart Failure✨ | Transthyretin Cardiac AmyloidosisHeart Failure+4 | Frederick L. Ruberg, MDMathew S. Maurer, MD | Transthyretin Cardiac Amyloidosis in Older Black and Hispanic Individuals With Heart Failure | — | TransthyretinCardiac Amyloidosis+6 | — | 17m 34s | |
| 8/27/25 | Clinical Outcomes With Personalized Accelerated Physiologic Pacing in HFpEF✨ | Heart FailurePhysiologic Pacing+3 | Margaret Infeld, MD, MS | Clinical Outcomes With Personalized Accelerated Physiologic Pacing in Heart Failure With Preserved Ejection Fraction | — | Heart FailurePhysiologic Pacing+3 | — | 20m 52s | |
| 7/30/25 | Preserving and Promoting Clinical Trial Representativeness✨ | clinical trialsrepresentativeness+3 | Roxana Mehran, MD | Preserving and Promoting Clinical Trial Representativeness | — | clinical trial representativenessmedical research strategies+3 | — | 16m 03s | |
| 6/18/25 | CT Angiography, Healthy Lifestyle Behaviors, and Preventive Therapy✨ | CT AngiographyHealthy Lifestyle+3 | Michael McDermott, MBChBPamela S. Douglas, MD | CT Angiography, Healthy Lifestyle Behaviors, and Preventive TherapyThe Last Mile in Prevention—Can Coronary CT Angiography Help? | — | CT AngiographyHealthy Lifestyle Behaviors+3 | — | 18m 51s | |
| 4/30/25 | Cardiomyopathy-Associated Gene Variants in Atrial Fibrillation✨ | cardiomyopathyatrial fibrillation+3 | Leonoor F. J. M. WijdeveldSean J. Jurgens | Cardiomyopathy-Associated Gene Variants in Atrial Fibrillation | — | cardiomyopathyatrial fibrillation+3 | — | 15m 28s | |
| 3/26/25 | Encouraging Pharmacist Referrals for Evidence-Based Statin Initiation✨ | pharmacist referralsstatin initiation+3 | Alexander C. Fanaroff, MD, MHS | JAMA Network | — | pharmacist referralsstatin+4 | — | 19m 30s | |
| 2/5/25 | Sodium Reduction Legislation and Urinary Sodium and Blood Pressure in South Africa✨ | sodium reductionblood pressure+4 | Thomas Gaziano, MDDaniel W. Jones, MD | Sodium Reduction Legislation and Urinary Sodium and Blood Pressure in South AfricaDietary Sodium- and Potassium-Enriched Salt Substitutes—The Tipping Point? | — | sodium reductionblood pressure+4 | — | 18m 27s | |
| 11/6/24 | Prevalence of HFpEF in Isolated Severe Secondary Tricuspid Regurgitation✨ | heart failuretricuspid regurgitation+3 | Barry A. Borlaug, MDJwan A. Naser, MBBS | Prevalence of HFpEF in Isolated Severe Secondary Tricuspid Regurgitation | — | HFpEFtricuspid regurgitation+3 | — | 10m 52s | |
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 9/25/24 | Heart Failure Medical Therapy Score and Clinical Outcomes | Interview with Paul L. Hess, MD, MHS, and Vincenzo B. Polsinelli, MD, authors of Hospital Heart Failure Medical Therapy Score and Associated Clinical Outcomes and Costs. Hosted by James E. Udelson, MD. Related Content: Hospital Heart Failure Medical Therapy Score and Associated Clinical Outcomes and Costs | — | ||||||
| 8/28/24 | Prevalence, Cardiac Phenotype, and Outcomes of Transthyretin Variants | Interview with Luis R. Lopes, PhD, author of Prevalence, Cardiac Phenotype, and Outcomes of Transthyretin Variants in the UK Biobank Population, and Senthil Selvaraj, MD, MS, MA, author of Genotype- vs Phenotype-Guided Approaches to Improve ATTR Detection. Hosted by Sharlene M. Day, MD. Related Content: Prevalence, Cardiac Phenotype, and Outcomes of Transthyretin Variants in the UK Biobank Population Genotype- vs Phenotype-Guided Approaches to Improve ATTR Detection | — | ||||||
| 7/31/24 | Leadless Ultrasound-Based Cardiac Resynchronization System in Heart Failure | Interview with Jagmeet P. Singh, MD, DPhil, author of Leadless Ultrasound-Based Cardiac Resynchronization System in Heart Failure. Hosted by Kristen K. Patton, MD. Related Content: Leadless Ultrasound-Based Cardiac Resynchronization System in Heart Failure | — | ||||||
| 6/12/24 | Postpartum Ambulatory Blood Pressure and New-Onset Hypertensive Disorders of Pregnancy | Interview with Alisse Hauspurg, MD, MS, author of Postpartum Ambulatory Blood Pressure Patterns Following New-Onset Hypertensive Disorders of Pregnancy. Hosted by Sadiya S. Khan, MD, MSc. Related Content: Postpartum Ambulatory Blood Pressure Patterns Following New-Onset Hypertensive Disorders of Pregnancy | — | ||||||
| 5/15/24 | Osteosarcopenia and Mortality in Older Adults Undergoing Transcatheter Aortic Valve Replacement | Interview with Jonathan Afilalo, MD, MSc, author of Osteosarcopenia and Mortality in Older Adults Undergoing Transcatheter Aortic Valve Replacement. Hosted by Robert O. Bonow, MD. Related Content: Osteosarcopenia and Mortality in Older Adults Undergoing Transcatheter Aortic Valve Replacement | — | ||||||
| 4/17/24 | Atrial Shunt Device Effects on Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction | Interview with Sanjiv J. Shah, MD, author of Atrial Shunt Device Effects on Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction: The REDUCE LAP-HF II Randomized Clinical Trial. Hosted by James E. Udelson, MD. Related Content: Atrial Shunt Device Effects on Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction | — | ||||||
| 3/27/24 | A Revised Definition of Left Bundle Branch Block Using Time to Notch in Lead I | Interview with Gaurav A. Upadhyay, MD, and Jeremy S. Treger, MD, PhD, authors of A Revised Definition of Left Bundle Branch Block Using Time to Notch in Lead I. Hosted by Kristen K. Patton, MD. Related Content: A Revised Definition of Left Bundle Branch Block Using Time to Notch in Lead I | — | ||||||
| 2/21/24 | Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV | Interview with Michael T. Lu, MD, MPH, author of Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV: Mechanistic Substudy of the REPRIEVE Randomized Clinical Trial, and Matthew J. Feinstein, MD, MSc, author of Statins, Inflammation, and Tissue Context in REPRIEVE. Hosted by Robert Bonow, MD. Related Content: Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV Statins, Inflammation, and Tissue Context in REPRIEVE | — | ||||||
| 11/15/23 | Effect of Tafamidis on Cardiac Function in Patients With Transthyretin Amyloid Cardiomyopathy | Interview with Sanjiv J. Shah, MD, author of Effect of Tafamidis on Cardiac Function in Patients With Transthyretin Amyloid Cardiomyopathy: A Post Hoc Analysis of the ATTR-ACT Randomized Clinical Trial. Hosted by James E. Udelson, MD. Related Content: Effect of Tafamidis on Cardiac Function in Patients With Transthyretin Amyloid Cardiomyopathy | — | ||||||
| 10/25/23 | Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction | Interview with Divaka Perera, MA, MD, author of Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction: A Prespecified Secondary Analysis of the REVIVED-BCIS2 Trial, and Julio A. Panza, MD, author of Assessment of Myocardial Viability in Ischemic Cardiomyopathy—Scarred by the Data but Still Alive. Hosted by James E. Udelson, MD. Related Content: Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction Assessment of Myocardial Viability in Ischemic Cardiomyopathy—Scarred by the Data but Still Alive | — | ||||||
| 9/27/23 | Prevalence and Overlap of Cardiac, Renal, and Metabolic Conditions in US Adults, 1999-2020 | Interview with Muthiah Vaduganathan, MD, MPH, and John W. Ostrominski, MD, authors of Prevalence and Overlap of Cardiac, Renal, and Metabolic Conditions in US Adults, 1999-2020. Hosted by Sadiya Sana Khan, MD, MSc. Related Content: Prevalence and Overlap of Cardiac, Renal, and Metabolic Conditions in US Adults, 1999-2020 | — | ||||||
| 8/9/23 | Assisted Reproductive Technologies and Maternal Cardiovascular Disease | Interview with Maria C. Magnus, PhD, author of Maternal Risk of Cardiovascular Disease After Use of Assisted Reproductive Technologies, and Sadiya S. Khan, MD, MSc, author of Assisted Reproductive Technologies and Cardiovascular Disease Risk in Birthing Adults—When Null Results Matter. Hosted by Roxana Mehran, MD Related Content: Maternal Risk of Cardiovascular Disease After Use of Assisted Reproductive Technologies Assisted Reproductive Technologies and Cardiovascular Disease Risk in Birthing Adults—When Null Results Matter | — | ||||||
| 7/19/23 | Tracking Treatment Response in Cardiac Light-Chain Amyloidosis With Native T1 Mapping | Interview with Marianna Fontana, MD, PhD, author of Tracking Treatment Response in Cardiac Light-Chain Amyloidosis With Native T1 Mapping, and Sarah A. M. Cuddy, MB, BCh, BAO, author of Imaging Biomarkers in the Management of Light-Chain Cardiac Amyloidosis. Hosted by James Udelson, MD. Related Content: Tracking Treatment Response in Cardiac Light-Chain Amyloidosis With Native T1 Mapping Imaging Biomarkers in the Management of Light-Chain Cardiac Amyloidosis | — | ||||||
| 6/21/23 | Percutaneous Microaxial Left Ventricular Assist Device for Patients With Cardiogenic Shock | Interview with Robert W. Yeh, MD, MSc, author of Comparative Effectiveness of Percutaneous Microaxial Left Ventricular Assist Device vs Intra-Aortic Balloon Pump or No Mechanical Circulatory Support in Patients With Cardiogenic Shock, and David J. Cohen, MD, MSc, and Manesh R. Patel, MD, authors of Evidence Generation for Novel Cardiovascular Devices—Putting the Horse Back in Front of the Cart. Hosted by Ajay J. Kirtane, MD, SM. Related Content: Comparative Effectiveness of Percutaneous Microaxial Left Ventricular Assist Device vs Intra-Aortic Balloon Pump or No Mechanical Circulatory Support in Patients With Cardiogenic Shock Evidence Generation for Novel Cardiovascular Devices—Putting the Horse Back in Front of the Cart | — | ||||||
| 5/17/23 | Vigorous Exercise in Patients With Hypertrophic Cardiomyopathy | Interview with Sharlene M. Day, MD, Rachel Lampert, MD, and Michael J. Ackerman, MD, PhD, authors of Vigorous Exercise in Patients With Hypertrophic Cardiomyopathy. Hosted by Robert Bonow, MD. Related Content: Vigorous Exercise in Patients With Hypertrophic Cardiomyopathy | — | ||||||
Showing 25 of 118
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart Positions
2 placements across 2 markets.
Chart Positions
2 placements across 2 markets.
